(CRVO) CervoMed - Performance -59.2% in 12m
CRVO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-79.70%
#130 in Peer-Group
Rel. Strength
6.70%
#7181 in Stock-Universe
Total Return 12m
-59.22%
#146 in Peer-Group
Total Return 5y
-90.61%
#119 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 19.77 USD |
| 52 Week Low | 1.90 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 41.94 |
| Buy/Sell Signal +-5 | 1.03 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CRVO (-59.2%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CRVO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRVO
| Total Return (including Dividends) | CRVO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -18.54% | 0.53% | 3.75% |
| 3 Months | -24.22% | 21.37% | 25.32% |
| 12 Months | -59.22% | -9.11% | 13.11% |
| 5 Years | -90.61% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | CRVO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -92.5% | -5.7% | 80.3% |
| 3 Months | -88.8% | 79.4% | 97.2% |
| 12 Months | -65.6% | -86.9% | 45.4% |
| 5 Years | -71.3% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th13.00 | -18.97% | -21.49% |
| 3 Month | %th7.50 | -37.56% | -39.53% |
| 12 Month | %th28.00 | -55.13% | -63.94% |
| 5 Years | %th41.00 | -87.31% | -95.52% |
FAQs
Does CervoMed (CRVO) outperform the market?
No,
over the last 12 months CRVO made -59.22%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months CRVO made -24.22%, while XBI made 21.37%.
Performance Comparison CRVO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CRVO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.9% | -22.3% | 183.4% | -72% |
| US NASDAQ 100 | QQQ | 5.3% | -22.7% | 181.8% | -71% |
| German DAX 40 | DAX | 4% | -18.7% | 170.6% | -90% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.8% | -22.3% | 179.6% | -81% |
| Hongkong Hang Seng | HSI | 6.3% | -21.6% | 162.9% | -98% |
| India NIFTY 50 | INDA | 6.6% | -19.4% | 182.8% | -58% |
| Brasil Bovespa | EWZ | 6.6% | -24.4% | 161.3% | -67% |
CRVO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.2% | -22.1% | 178.8% | -83% |
| Consumer Discretionary | XLY | 6.6% | -20.5% | 191.1% | -75% |
| Consumer Staples | XLP | 7.1% | -18.9% | 182.8% | -67% |
| Energy | XLE | 2.8% | -25.3% | 187.1% | -61% |
| Financial | XLF | 7.2% | -21.3% | 180.8% | -87% |
| Health Care | XLV | 7.6% | -19.6% | 192.3% | -54% |
| Industrial | XLI | 5.8% | -21.7% | 176.5% | -84% |
| Materials | XLB | 5% | -22.3% | 179.8% | -65% |
| Real Estate | XLRE | 7% | -18.4% | 184.5% | -71% |
| Technology | XLK | 4.2% | -25.7% | 179.3% | -69% |
| Utilities | XLU | 7.3% | -19.8% | 181% | -81% |
| Aerospace & Defense | XAR | 5.2% | -22.3% | 165.2% | -107% |
| Biotech | XBI | 4.4% | -19.1% | 197.4% | -50% |
| Homebuilder | XHB | 7.1% | -24.5% | 191.3% | -63% |
| Retail | XRT | 5.8% | -20.1% | 188% | -69% |
CRVO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.2% | -25.4% | 190% | -55% |
| Natural Gas | UNG | 8.2% | -8.1% | 202.6% | -53% |
| Gold | GLD | 7.4% | -17.7% | 165.5% | -99% |
| Silver | SLV | 4.6% | -18.2% | 167.7% | -78% |
| Copper | CPER | -0.7% | -28.6% | 162.9% | -78% |
CRVO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 8.7% | -19.6% | 187.1% | -56% |
| iShares High Yield Corp. Bond | HYG | 6.5% | -19.8% | 185% | -69% |